Prognostic Significance of Concurrent MYC, BCL2 and/or BCL6 Expression in Diffuse Large B-Cell Lymphoma

The significance of MUM1, BCL-6, and CD10 in identification of the cellular origin of head and neck diffuse large B-cell lymphomas. An immuno-histochemical study.

Inverse correlation of concurrent BCL2, and C MYC expressions and CD30 ‎positivity as regard the Prognostic significance in diffuse large B-cell ‎lymphoma

Evaluation of t(14;18)(q32;q21) and BCL2 protein and their prognostic role in follicular lymphoma

Bone marrow infiltration in diffuse large B-cell lymphoma: impact of 18FDG-PET/CT in detection and prediction of therapy outcome

DIAGNOSTIC AND PREDICTIVE VALUE OF SURVIVIN, P63 ANDCD15 IN NON HODGKIN'S LYMPHOMAS

Prognostic value of BCL-2, cyclin E and cyclin dependent kinase inhibitor (P27) genes expression in non-Hodgkin lymphoma

Prognostic Significance of Beclin 1 Expression in Diffuse Large B Cell Lymphoma Patients Receiving Immuno-chemotherapy at Zagazig University and Health Insurance Hospitals

Clinicopathological Significance of A20 Genetic Mutation in Diffuse Large B-Cell Lymphoma

Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Diffuse Large B Cell Lymphoma Patients Treated with RCHOP